TLG Capital, a leading Africa private credit fund manager, has completed a senior secured debt facility for a leading Ugandan healthcare distributor for up to US$ 2,000,000.
The financing provides for growth of the business, expanding distribution of critical pharmaceuticals in Uganda.
Frederick Mutebi Kitaba, a promoter of the transaction, said: “We have worked with TLG across other business activities for over a decade, and they have consistently proven themselves as a partner of choice. Their long-term commitment to our sector and to Uganda is invaluable.”
The deal represents TLG’s eighth investment into African healthcare, with previous investments spanning across Liberia, Nigeria, Uganda, Benin, Togo, Niger, Burkina Faso, Mali and Côte d'Ivoire. The firm’s track record in Uganda began in 2009, with an investment in Quality Chemicals Industries Limited, which manufactures life-saving antiretrovirals and antimalarials, treating millions of patients each year.
“At TLG, we are deeply encouraged by Uganda’s remarkable strides in human development over the past decade and a half — a testament to the resilience and potential of its people,” said Isha Doshi, CFO of TLG Capital.
“Since we first invested in 2009, Uganda has achieved a two-thirds reduction in child mortality and AIDS-related deaths have declined by 60%. These achievements are the result of targeted public and private investment to create affordable and high quality healthcare systems. When capital is deployed in Uganda with a long-term mindset, it delivers transformative results.”
About TLG Capital
TLG Capital is a leading Africa private credit fund. TLG has made 48 investments and achieved 31 exits in 20 African countries since inception. TLG has recently launched a new flagship fund, Africa Growth Impact Fund II (AGIF II), which is focused on small-and-medium enterprises in Africa, and is anchored by the IFC, Norfund, Swedfund, and Bpifrance. TLG is trusted by more than 100 investors globally.
For more information, visit www.tlgcapital.com.